Evidence map›Paper›PMID 32222066›Full record

ArticleThe journal of pathology. Clinical research2020

DICER1 screening in 15 paediatric paratesticular sarcomas unveils an unusual DICER1-associated sarcoma.

Maria Apellaniz-Ruiz, Noelle Cullinan, Ronald Grant, Paula Marrano, John R Priest, Paul S Thorner, Catherine Goudie, William D Foulkes

Open access · goldAbstract readCase Reports
In one paragraph

Article in The journal of pathology. Clinical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. PRAME protein expression in DICER1-related tumours.The journal of pathology. Clinical research · 2022
    Article
  5. Article
  6. DICER1 tumor predisposition syndrome: an evolving story initiated with the pleuropulmonary blastoma.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2022
    Review
  7. DICER1-sarcoma: an emerging entity.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2021
    Article
  8. Review
  9. The Histological Spectrum of DICER1-Associated Neoplasms.Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 2 countries.

Maria Apellaniz-RuizDepartment of Human Genetics, McGill University, Montréal, Canada.ORCID 0000-0002-2137-1439
Noelle CullinanDivision of Hematology-Oncology, The Hospital for Sick Children, and Department of Pediatrics, University of Toronto, Toronto, Canada.
Ronald GrantDivision of Hematology-Oncology, The Hospital for Sick Children, and Department of Pediatrics, University of Toronto, Toronto, Canada.
Paula MarranoDivision of Pathology, The Hospital for Sick Children, Toronto, Canada.
John R PriestMinneapolis, MN, USA.
Paul S ThornerDivision of Pathology, The Hospital for Sick Children, Toronto, Canada.
Catherine GoudieDivision of Hematology-Oncology, Montréal Children's Hospital, Department of Pediatrics, McGill University, Montréal, Canada.
William D FoulkesDepartment of Human Genetics, McGill University, Montréal, Canada.ORCID 0000-0001-7427-4651
University of Toronto · CAHospital for Sick Children · CAJewish General Hospital · CAMcGill University Health Centre · CAMinneapolis Institute of Arts · USMontreal Children's Hospital · CA

Funding

CIHR FDN 148390
6 · The paper itself

Abstract

Individuals with DICER1 syndrome, a genetic disorder caused by pathogenic germline variants in DICER1, are at increased risk of developing a wide array of predominantly childhood onset conditions, including genitourinary sarcomas. However, data on DICER1 involvement in paratesticular sarcomas have not been published. Herein, we analyse a series of 15 paediatric paratesticular sarcomas and describe in detail the case of a male infant with a paratesticular myxoid tumour, considered to be a low-grade sarcoma, who also manifested a cystic nephroma, a classic DICER1 syndrome phenotype. He harboured a pathogenic germline DICER1 variant and different somatic hot-spot mutations in each tumour. The paratesticular tumour showed strong and diffuse expression for WT1 and CD10, an unusual immunophenotype in paediatric sarcomas, but typical of tumours of Müllerian origin. The tumour was postulated to arise from the appendix testis, a Müllerian remnant located in the paratestis. Such an origin would be analogous to other DICER1-associated non-epithelial gynaecological tumours, thought to arise from Müllerian derivatives. These findings point towards a key role of DICER1 in Müllerian-derived structures. Supporting this hypothesis is the fact that the other paratesticular sarcomas from the series were either negative or focally positive for WT1 and for CD10, and none had any DICER1 mutations. In summary, we present the first case of a paratesticular sarcoma associated with DICER1 syndrome, emphasising that paratesticular tumours with an unusual histological appearance may suggest an underlying DICER1 mutation, especially in the presence of a personal or family history of DICER1-associated disease. In this context, DICER1 mutation testing could lead to changes in clinical care including implementation of cancer care surveillance strategies.

Indexed as

Urologic NeoplasmsAdolescentBiomarkers, TumorChildChild, PreschoolDEAD-box RNA HelicasesGenetic Predisposition to DiseaseGerm-Line MutationHumansInfantMaleMullerian DuctsNeoplastic Syndromes, HereditaryRibonuclease IIISarcomaSoft Tissue NeoplasmsBiomarkers, TumorDEAD-box RNA HelicasesDICER1 protein, humanRibonuclease IIIDICER1 syndromeDICER1 testinggenitourinary tractMüllerian originparatesticular sarcoma

Identifiers

PMID32222066
PMCPMC7339209
OpenAlexW3014062098

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.